A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without VX-970 in Metastatic Urothelial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2017
At a glance
- Drugs M 6620 (Primary) ; Cisplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- 29 Sep 2016 Status changed from suspended to recruiting.
- 22 Aug 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Aug 2018.
- 22 Aug 2016 Status changed from not yet recruiting to suspended.